The pandemic has exacerbated not only cardiovascular care, but also the mental health of patients, noted Mariana Garcia, MD, cardiology fellow in the Academic Clinical Investigator Pathway at Emory University and member of T32, Multidisciplinary Research Training to Reduce Inequalities in Cardiovascular Health (METRIC).
Not only has the pandemic exacerbated cardiovascular care, but it has had devastating effects on patients' mental health, noted Mariana Garcia, MD, cardiology fellow in the Academic Clinical Investigator Pathway at Emory University and member of T32, Multidisciplinary Research Training to Reduce Inequalities in Cardiovascular Health (METRIC).
Transcript
Will cardiovascular outcomes be exacerbated by the pandemic?
So, with the pandemic, it's been kind of both ways. On one way, we know that cardiovascular care has been affected by the pandemic, because data have shown that there's been delay in seeking care and receiving timely treatment. But on the other end, we're also seeing the implications of COVID-19 for mental health, which have been devastating. So I think, with these 2 pathways underway during the pandemic—it wasn't part of our study or what were what we were looking into—I think we have to be ready for what cardiovascular outcomes will be from this.
Is there a need for additional preventive measures to avoid adverse outcomes in patients with no comorbidities?
One treatment pathway could definitely be whether medications such as antidepressants or other psychotropic medications could be helpful to even lower cardiovascular outcomes, right? Data [have] been mixed, with no strong conclusion that we can make, but because it hasn't necessarily translated to decreased event rates, it's definitely one pathway to explore for future research.
Another possibility is treating the inflammation. There's a huge number of researchers out there looking into that. However, the one thing that we do want to emphasize is that making sure that patients are on the appropriate guideline-directed secondary preventative medications is extremely important. Because it is possible that these medications, such as statin and aspirin, may be protective for these effects of stress in everyday life. So those are 2 pathways.
And I think just overall, equally important is that our findings suggest that as cardiologists, we should really be cognizant of considering regular psychological assessments, which we might necessarily do in our everyday practice, and equally important [is to] explore treatment modalities. In addition to traditional medical therapy and cardiac rehab, maybe consider meditation and relaxation techniques or any other holistic approach. So those are the avenues we can think of.
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More
Value-Based Care Is Key to Bringing Cardiology Breakthroughs to Those Who Will Benefit Most
March 13th 2025On December 10, 2024, cardiologists, researchers, and value-based care experts gathered in Dallas, Texas, to discuss best practices for implementing advances in cardiology care with a value-based mindset, spanning the care continuum from prevention to treatment.
Read More